Trial
NCT04323124
Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer
Collaborators
—
Condition
Healthy
Intervention
PF-07059013
Why stopped
Study was terminated as it did not demonstrate sufficient pharmacological effect. Termination was not related to safety reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19